CRDL
Cardiol Therapeutics Inc.
$1.11
-0.04 (-3.48%)
At close · Jul 15
Market Cap
$141.78M
Shares
115,272,240
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.11
Open$1.15
Day$1.08–1.18
52W$0.88–1.71
Avg vol 30d504K
Short int2.2M · 1.9% float · 6.5d
Short vol42%
DataJan 2020–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 16.7 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+0%
above
Price vs 50-day avg
−4%
below
RSI (14)
54
neutral
MACD trend
Positive
52-week position
28%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+4%
trailing
6-month return
+9%
trailing
YTD return
+16%
this year
Relative strength
−1%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow
Accumulating
3 of 47 funds reported for Jun 30 · net +22.3K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.92% of float · ▲ +6.4% MoM · 6.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
47 holders — near 3-yr high, broad support
Squeeze score
61
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
68%
annualized · 1-yr
Max drawdown
−39%
past year
ATR
5.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+0%
Bullish
Price vs 50-day avg
−4%
Neutral
RSI (14)
54
Neutral
MACD trend
Positive
Bullish
52-week position
28%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow
Accumulating
3 of 47 funds reported for Jun 30 · net +22.3K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.92% of float · ▲ +6.4% MoM · 6.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
47 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $1
Now $1 · 28%
52-wk high $2
vs 200-day avg +0%
vs 50-day avg -4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CRDL
this stock
Cardiol Therapeutics Inc.
|
$141.78M | +16.4% | — | — | 1.9% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$53.48B | +5.5% | — | — | 0.2% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$51.90B | — | — | — | 0.0% |
|
GALDY
Galderma Group AG/ADR
|
$49.13B | -0.2% | — | — | 0.0% |
|
HLN
Haleon plc
|
$44.62B | -3.6% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CRDL | +11.0% | +3.7% | +8.8% | +4.7% | +16.4% |
| SPY | +1.3% | -0.2% | +10.1% | +1.1% | +10.7% |
| vs SPY | +9.7% | +3.9% | -1.3% | +3.6% | +5.7% |